Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-240099
Filing Date
2014-06-18
Accepted
2014-06-18 08:22:59
Documents
4
Period of Report
2014-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d745034d6k.htm 6-K 9348
2 EX-99.1 d745034dex991.htm EX-99.1 5109
3 GRAPHIC g745034img1.jpg GRAPHIC 9452
4 GRAPHIC g745034img2.jpg GRAPHIC 6273
  Complete submission text file 0001193125-14-240099.txt   37438
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-16174 | Film No.: 14926745
SIC: 2834 Pharmaceutical Preparations